Primaquine Phosphate Tablets Market - Global Forecast 2026-2032

The primaquine phosphate tablets market serves a vital role in global malaria treatment strategies, offering unique value for both radical cure and transmission control initiatives. Stakeholders require trustworthy insights into market forces, procurement changes, and compliance issues to inform operational and sourcing decisions.

Market Snapshot: Primaquine Phosphate Tablets Market Overview

The Primaquine Phosphate Tablets Market grew from USD 168.39 million in 2025 to USD 177.22 million in 2026. It is expected to continue growing at a CAGR of 5.84%, reaching USD 250.56 million by 2032. This trajectory reflects intensifying efforts to control and eliminate malaria, shaped by evolving procurement models, public health policies, and increasing regulatory scrutiny.

Scope & Segmentation of the Primaquine Phosphate Tablets Market

This report delivers an in-depth analysis of the global primaquine phosphate tablets market, focusing on critical demand drivers, procurement frameworks, and supply chain mechanics across key segments and regions.

Product Types: Specialized formulations tailored to stability, ease of use, and program requirements.
Dosage Strengths: Differentiation caters to guideline-driven standardization as well as individually tailored regimens, meeting diverse national protocols.
Application Needs: Encompasses radical cure for Plasmodium vivax/ovale and transmission reduction in Plasmodium falciparum malaria.
Distribution Channels: Includes structured public-sector tenders, hospital and institutional networks, retail pharmacy channels, and other specialized routes.
Geographical Regions: Coverage spans the Americas, Europe, Middle East, Africa, and Asia-Pacific, reflecting local epidemiology, regulation, and health-system maturity.
Procurement and Quality Control Models: Evaluates standards such as serialization, packaging configuration, stability requirements, and documentation practices.
Diagnostic Technology Use: Integrates G6PD testing advances, from laboratory-based to point-of-care, influencing utilization and safety measures.

Key Takeaways for Decision-Makers

Primaquine phosphate tablets maintain a pivotal clinical position for radical cure outcomes and transmission suppression, intersecting both patient and population-level goals.
Procurement prioritizes reliability, quality systems, and traceable supply, distinguishing mature manufacturers from less-capable suppliers particularly in competitive tenders.
Market dynamics are influenced by epidemiology shifts, public health initiatives, and climate or migration-driven variations, requiring adaptability from suppliers and distributors.
G6PD deficiency protocols and diagnostic access remain critical; suppliers that enable safe use through clear labeling and education enhance adoption and minimize safety events.
Operational resilience, buffer inventory management, and rigorous change controls are increasingly valued in the context of ongoing global supply disruptions.
Regional market performance is tightly linked to importer capability, health-system responsiveness, and ability to comply with diverse regulatory and audit demands.

Tariff Impact: Navigating the 2025 U.S. Policy Shift

United States tariff policy changes in 2025 are set to affect primaquine phosphate tablets primarily through upstream cost volatility, trade routing decisions, and procurement contract risk management. Although most finished products are not destined for U.S. end-markets, the global interconnection of supply chains means changes in tariff structures can increase input costs, require renegotiation of supplier terms, impact custom clearance times, and incentivize diversification of sourcing and inventory strategies.

Cost pressures may narrow tender participation and complicate supplier selection, especially when combined with regulatory demands for auditable manufacturing, documentation, and quality assurance. Enhanced inventory strategies and revised contract terms are commonly deployed to mitigate exposure, but working capital and expiry risks become more prominent as a result. This environment rewards organizations with robust supply networks and the agility to respond to sudden trade or sourcing adjustments.

Methodology & Data Sources

This market assessment leverages a structured approach combining secondary research, targeted stakeholder interviews, and ongoing data triangulation. Market scope and terminology are validated through consultation with manufacturers, procurement entities, distributors, and malaria program experts, ensuring all findings reflect real-world procurement and supply realities.

Why This Report Matters

Supports senior decision-makers as they adapt sourcing, manufacturing, and risk management approaches in a rapidly evolving regulatory and supply landscape.
Enables strategic alignment with buyer requirements, guiding prioritization of compliance, supply resilience, and channel-specific execution.

Access to these actionable insights is essential for navigating increasingly complex tenders, managing program-driven demand, and strengthening competitive positioning across regions.

Conclusion

Safety governance, procurement quality, and supply resilience will define success in the primaquine phosphate tablets market. Decision-makers who align operational execution with these priorities position their organizations for sustained performance.

1. Preface

1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders

2. Research Methodology

2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations

3. Executive Summary

3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap

4. Market Overview

4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy

5. Market Insights

5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025

8. Primaquine Phosphate Tablets Market, by Strength

8.1. 15 mg
8.2. 26.3 mg
8.3. 7.5 mg

9. Primaquine Phosphate Tablets Market, by Treatment Regimen

9.1. Combination Therapy
9.2. Monotherapy

10. Primaquine Phosphate Tablets Market, by Packaging Type

10.1. Blister Pack
10.2. Bottle

11. Primaquine Phosphate Tablets Market, by Distribution Channel

11.1. Hospital Pharmacy
11.2. Online Pharmacy
11.3. Retail Pharmacy

12. Primaquine Phosphate Tablets Market, by Patient Age

12.1. Adult
12.2. Pediatric

13. Primaquine Phosphate Tablets Market, by Region

13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific

14. Primaquine Phosphate Tablets Market, by Group

14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO

15. Primaquine Phosphate Tablets Market, by Country

15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea

16. United States Primaquine Phosphate Tablets Market
17. China Primaquine Phosphate Tablets Market

18. Competitive Landscape

18.1. Market Concentration Analysis, 2025
18.1.1. Concentration Ratio (CR)
18.1.2. Herfindahl Hirschman Index (HHI)
18.2. Recent Developments & Impact Analysis, 2025
18.3. Product Portfolio Analysis, 2025
18.4. Benchmarking Analysis, 2025
18.5. Actiza Pharmaceutical Pvt. Ltd.
18.6. AdvaCare Pharma
18.7. Aurobindo Pharma Limited
18.8. Cipla Limited
18.9. Devlife Corporation Private Limited
18.10. Healthy Life Pharma Pvt. Ltd.
18.11. Hetero Drugs Limited
18.12. Intas Pharmaceuticals Limited
18.13. Ipca Laboratories Limited
18.14. Johnlee Pharmaceuticals Pvt. Ltd.
18.15. Lexicare Pharma Pvt. Ltd.
18.16. Livealth BioPharma Pvt. Ltd.
18.17. Lupin Limited
18.18. Marshall Healthcare
18.19. Medico Remedies Limited
18.20. Natco Pharma Limited
18.21. Sandoz International GmbH
18.22. Sun Pharmaceutical Industries Limited
18.23. Taj Pharmaceuticals Limited
18.24. Teva Pharmaceutical Industries Ltd.
18.25. Viatris Inc.

List of Figures

FIGURE 1. GLOBAL PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL PRIMAQUINE PHOSPHATE TABLETS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL PRIMAQUINE PHOSPHATE TABLETS MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY STRENGTH, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY TREATMENT REGIMEN, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PACKAGING TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PATIENT AGE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. UNITED STATES PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 13. CHINA PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, 2018-2032 (USD MILLION)

List of Tables

TABLE 1. GLOBAL PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY STRENGTH, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY 15 MG, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY 15 MG, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY 15 MG, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY 26.3 MG, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY 26.3 MG, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY 26.3 MG, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY 7.5 MG, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY 7.5 MG, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY 7.5 MG, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY TREATMENT REGIMEN, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY COMBINATION THERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY COMBINATION THERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY COMBINATION THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY MONOTHERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY MONOTHERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY MONOTHERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY BLISTER PACK, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY BLISTER PACK, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY BLISTER PACK, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY BOTTLE, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY BOTTLE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY BOTTLE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY ONLINE PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY ONLINE PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY RETAIL PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY RETAIL PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PATIENT AGE, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY ADULT, BY REGION, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY ADULT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY ADULT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PEDIATRIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. AMERICAS PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 45. AMERICAS PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY STRENGTH, 2018-2032 (USD MILLION)
TABLE 46. AMERICAS PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY TREATMENT REGIMEN, 2018-2032 (USD MILLION)
TABLE 47. AMERICAS PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
TABLE 48. AMERICAS PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 49. AMERICAS PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PATIENT AGE, 2018-2032 (USD MILLION)
TABLE 50. NORTH AMERICA PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 51. NORTH AMERICA PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY STRENGTH, 2018-2032 (USD MILLION)
TABLE 52. NORTH AMERICA PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY TREATMENT REGIMEN, 2018-2032 (USD MILLION)
TABLE 53. NORTH AMERICA PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
TABLE 54. NORTH AMERICA PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 55. NORTH AMERICA PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PATIENT AGE, 2018-2032 (USD MILLION)
TABLE 56. LATIN AMERICA PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 57. LATIN AMERICA PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY STRENGTH, 2018-2032 (USD MILLION)
TABLE 58. LATIN AMERICA PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY TREATMENT REGIMEN, 2018-2032 (USD MILLION)
TABLE 59. LATIN AMERICA PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
TABLE 60. LATIN AMERICA PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 61. LATIN AMERICA PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PATIENT AGE, 2018-2032 (USD MILLION)
TABLE 62. EUROPE, MIDDLE EAST & AFRICA PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 63. EUROPE, MIDDLE EAST & AFRICA PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY STRENGTH, 2018-2032 (USD MILLION)
TABLE 64. EUROPE, MIDDLE EAST & AFRICA PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY TREATMENT REGIMEN, 2018-2032 (USD MILLION)
TABLE 65. EUROPE, MIDDLE EAST & AFRICA PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
TABLE 66. EUROPE, MIDDLE EAST & AFRICA PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 67. EUROPE, MIDDLE EAST & AFRICA PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PATIENT AGE, 2018-2032 (USD MILLION)
TABLE 68. EUROPE PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 69. EUROPE PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY STRENGTH, 2018-2032 (USD MILLION)
TABLE 70. EUROPE PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY TREATMENT REGIMEN, 2018-2032 (USD MILLION)
TABLE 71. EUROPE PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
TABLE 72. EUROPE PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 73. EUROPE PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PATIENT AGE, 2018-2032 (USD MILLION)
TABLE 74. MIDDLE EAST PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 75. MIDDLE EAST PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY STRENGTH, 2018-2032 (USD MILLION)
TABLE 76. MIDDLE EAST PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY TREATMENT REGIMEN, 2018-2032 (USD MILLION)
TABLE 77. MIDDLE EAST PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
TABLE 78. MIDDLE EAST PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 79. MIDDLE EAST PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PATIENT AGE, 2018-2032 (USD MILLION)
TABLE 80. AFRICA PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 81. AFRICA PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY STRENGTH, 2018-2032 (USD MILLION)
TABLE 82. AFRICA PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY TREATMENT REGIMEN, 2018-2032 (USD MILLION)
TABLE 83. AFRICA PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
TABLE 84. AFRICA PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 85. AFRICA PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PATIENT AGE, 2018-2032 (USD MILLION)
TABLE 86. ASIA-PACIFIC PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 87. ASIA-PACIFIC PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY STRENGTH, 2018-2032 (USD MILLION)
TABLE 88. ASIA-PACIFIC PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY TREATMENT REGIMEN, 2018-2032 (USD MILLION)
TABLE 89. ASIA-PACIFIC PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
TABLE 90. ASIA-PACIFIC PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 91. ASIA-PACIFIC PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PATIENT AGE, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 93. ASEAN PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 94. ASEAN PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY STRENGTH, 2018-2032 (USD MILLION)
TABLE 95. ASEAN PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY TREATMENT REGIMEN, 2018-2032 (USD MILLION)
TABLE 96. ASEAN PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
TABLE 97. ASEAN PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 98. ASEAN PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PATIENT AGE, 2018-2032 (USD MILLION)
TABLE 99. GCC PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 100. GCC PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY STRENGTH, 2018-2032 (USD MILLION)
TABLE 101. GCC PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY TREATMENT REGIMEN, 2018-2032 (USD MILLION)
TABLE 102. GCC PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
TABLE 103. GCC PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 104. GCC PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PATIENT AGE, 2018-2032 (USD MILLION)
TABLE 105. EUROPEAN UNION PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 106. EUROPEAN UNION PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY STRENGTH, 2018-2032 (USD MILLION)
TABLE 107. EUROPEAN UNION PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY TREATMENT REGIMEN, 2018-2032 (USD MILLION)
TABLE 108. EUROPEAN UNION PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
TABLE 109. EUROPEAN UNION PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 110. EUROPEAN UNION PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PATIENT AGE, 2018-2032 (USD MILLION)
TABLE 111. BRICS PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 112. BRICS PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY STRENGTH, 2018-2032 (USD MILLION)
TABLE 113. BRICS PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY TREATMENT REGIMEN, 2018-2032 (USD MILLION)
TABLE 114. BRICS PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
TABLE 115. BRICS PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 116. BRICS PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PATIENT AGE, 2018-2032 (USD MILLION)
TABLE 117. G7 PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 118. G7 PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY STRENGTH, 2018-2032 (USD MILLION)
TABLE 119. G7 PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY TREATMENT REGIMEN, 2018-2032 (USD MILLION)
TABLE 120. G7 PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
TABLE 121. G7 PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 122. G7 PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PATIENT AGE, 2018-2032 (USD MILLION)
TABLE 123. NATO PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 124. NATO PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY STRENGTH, 2018-2032 (USD MILLION)
TABLE 125. NATO PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY TREATMENT REGIMEN, 2018-2032 (USD MILLION)
TABLE 126. NATO PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
TABLE 127. NATO PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 128. NATO PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PATIENT AGE, 2018-2032 (USD MILLION)
TABLE 129. GLOBAL PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 130. UNITED STATES PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 131. UNITED STATES PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY STRENGTH, 2018-2032 (USD MILLION)
TABLE 132. UNITED STATES PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY TREATMENT REGIMEN, 2018-2032 (USD MILLION)
TABLE 133. UNITED STATES PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
TABLE 134. UNITED STATES PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 135. UNITED STATES PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PATIENT AGE, 2018-2032 (USD MILLION)
TABLE 136. CHINA PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 137. CHINA PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY STRENGTH, 2018-2032 (USD MILLION)
TABLE 138. CHINA PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY TREATMENT REGIMEN, 2018-2032 (USD MILLION)
TABLE 139. CHINA PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
TABLE 140. CHINA PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 141. CHINA PRIMAQUINE PHOSPHATE TABLETS MARKET SIZE, BY PATIENT AGE, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Primaquine Phosphate Tablets market report include:

Actiza Pharmaceutical Pvt. Ltd.
AdvaCare Pharma
Aurobindo Pharma Limited
Cipla Limited
Devlife Corporation Private Limited
Healthy Life Pharma Pvt. Ltd.
Hetero Drugs Limited
Intas Pharmaceuticals Limited
Ipca Laboratories Limited
Johnlee Pharmaceuticals Pvt. Ltd.
Lexicare Pharma Pvt. Ltd.
Livealth BioPharma Pvt. Ltd.
Lupin Limited
Marshall Healthcare
Medico Remedies Limited
Natco Pharma Limited
Sandoz International GmbH
Sun Pharmaceutical Industries Limited
Taj Pharmaceuticals Limited
Teva Pharmaceutical Industries Ltd.
Viatris Inc.

Table Information

Report Attribute	Details
No. of Pages	198
Published	January 2026
Forecast Period	2026 - 2032
Estimated Market Value ( USD ) in 2026	$ 177.22 Million
Forecasted Market Value ( USD ) by 2032	$ 250.56 Million
Compound Annual Growth Rate	5.8%
Regions Covered	Global
No. of Companies Mentioned	22

License	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access	This is a single user license, allowing one user access to the product.	€3511EUR$3,939USD£3,045GBP
1 - 5 USER LICENSE PDF, Excel and Online Access	This is a 1-5 user license, allowing up to five users have access to the product.	€3787EUR$4,249USD£3,285GBP
SITE LICENSE PDF, Excel and Online Access	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5133EUR$5,759USD£4,452GBP
ENTERPRISE LICENSE PDF, Excel and Online Access	This is an enterprise license, allowing all employees within your organization access to the product.	€6212EUR$6,969USD£5,387GBP

Market Snapshot: Primaquine Phosphate Tablets Market Overview

Scope & Segmentation of the Primaquine Phosphate Tablets Market

Key Takeaways for Decision-Makers

Tariff Impact: Navigating the 2025 U.S. Policy Shift

Methodology & Data Sources

Why This Report Matters

Conclusion

Table of Contents

Companies Mentioned

Table Information

Related Topics

Related Reports

Phosphate Market by Type (Phosphoric Acid, Ammonium, Calcium, Sodium, Potassium), Type of Resource (Sedimentary Marine Deposits, Igneous and Weathered), Application (Fertilizers, Animal Feed, Food Additives), and Region - Global Forecast to 2029

Diammonium Hydrogen Phosphate - Global Strategic Business Report

Primaquine Phosphate (CAS 63-45-6) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029

Primaquine (CAS 90-34-6) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029

Piperazine Phosphate Tablets Market - Global Forecast 2025-2030